WHIPPANY, N.J., Aug. 18, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK), is pleased to report that 100% wholly owned subsidiary CannabisKing Distribution, LLC, in just one week after training, completes multiple sales for the AccuVape product line in Nevada, Colorado, New Jersey and New York. After such an initial sales success, CannabisKing has lined up dozens of sales calls over the next few weeks, most from new client referrals.  CannabisKing is confident they will be able to introduce the AccuVape line to a larger market share, nationally.

New retail sellers of the AccuVape line have an over 90% retention rate of the product line and most experience an increase in monthly orders of the AccuVape line, once the location is established as an Authorized Retailer.  CannabisKing has sales representatives in New Jersey, New York, Nevada, Colorado, Arizona, Oregon, Washington, Texas and California, with Florida also soon to be added. The number of accounts is expected to exponentially grow in the coming weeks due to the extensive initial positive feedback from current accounts.

In the next few weeks, CannabisKing expects to begin marketing the additional product lines currently listed on the newly launched cannabiskinghq.com website. Additionally, CannabisKing is currently in the process of adding new product lines and services for distribution.

David Cunic, CEO of Pazoo, states, “We are very pleased at how strongly our sales reps have come out of the gates and have secured sales so quickly after the well planned and organized training by the AccuVape Management Team. The wonderful thing from an operational standpoint for Pazoo is that our current sales reps for the testing labs are now excited to be busy and all other CannabisKing reps are commission based.  There is not an additional single overhead cost for Pazoo or our subsidiary companies in making these sales. We felt strongly to not simply sit back and wait for things to happen with the testing labs.  We saw an opportunity to be proactive and go after sales and make things happen. We will be even more aggressive moving forward to diversify and expand the revenue streams of the overall company. ” 

Hilary Dulany, founder and CEO of AccuVape, states, “We are not only pleased with the competency of the sales team that Pazoo has assembled, but are also very excited to see the professional, aggressive approach they are taking in representing the AccuVape line.  Our initial impression and beginning relationship with Pazoo leads us to believe they will be one of our major distribution channels for our brand and custom services.”

Safe Harbor Statement:
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.

ABOUT PAZOO Inc.
Pazoo, Inc., is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly-owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry-leading laboratory testing of cannabis. Harris Lee’s and MA’s license agreements with Steep Hill Labs, Inc. allows the Pazoo subsidiaries to use Steep Hill’s top-rated testing protocols in select markets as we expand throughout the USA. Pazoo’s subsidiaries are currently licensed to test cannabis in Nevada, Oregon and Colorado, with other states to come. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website www.pazoo.com.

ABOUT STEEP HILL LABS Inc.
Founded in California in 2008, Steep Hill is a science and technology firm that has become the industry leader in cannabis testing and analytics. With owned and licensed labs in four U.S. states and plans to add labs in New Mexico, Oregon and possibly Jamaica in 2015, Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California – the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann™, QuantaCann2™ and GenKit™. Steep Hill provides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing, mapping and trademark protection services for the industry as well.

SOURCE Pazoo, Inc.